bismuth has been researched along with Duodenal Ulcer in 274 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 121 (44.16) | 18.7374 |
| 1990's | 131 (47.81) | 18.2507 |
| 2000's | 17 (6.20) | 29.6817 |
| 2010's | 5 (1.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreev, DN; Bektemirova, LG; Dicheva, DT; Lobanova, EG; Maev, IV; Veliev, AM; Zaborovskii, AV | 1 |
| Chen, Y; Du, Y; Li, Y; Liu, D; Lv, N; Pan, X; Wang, H; Wang, J; Wu, K; Xie, Y; Xu, J; Zeng, Z; Zhang, G | 1 |
| Baghbanian, M; Mirvakili, M; Salmanroghani, H; Salmanroghani, R; Sanati, G; Yazdian, P | 1 |
| An, HJ; Chen, Y; Cheng, H; Cui, M; Dong, L; Gao, H; Gao, W; Gong, J; Hu, F; Jiang, B; Jiang, K; Li, J; Li, Y; Liang, H; Meng, F; Sheng, J; Wang, B; Wang, H; Wei, H; Yang, L; Yang, Y; Zhang, G; Zhang, S; Zhao, P; Zhao, Y; Zuo, X | 1 |
| Golubev, NN; Maev, IV; Samsonov, AA | 1 |
| Bari, Z; Fakheri, H; Hosseini, V; Taghvaei, T | 1 |
| Chan, CK; Fung, FM; Ho, VY; Hu, WH; Hung, WK; Lai, KC; Lam, SK; Szeto, ML; Tong, TS; Wong, BC; Wong, GS; Wong, WM; Xia, HH; Yip, AW; Yuen, MF | 1 |
| Nurbaev, FE; Orziev, ZM; Rakhimova, GSh | 1 |
| Laine, L | 1 |
| KOHLER, R; VON BOROS, J | 1 |
| HAUCH, E | 1 |
| TKACHENKO, GIa | 1 |
| Bazuro, G; Capurso, L; Fracasso, P; Koch, M; Luzietti, L; Palomba, M; Papi, C; Tarquini, M | 1 |
| Misiewicz, JJ | 2 |
| Hollanders, D; Martin, DF; May, SJ; Miller, JP; Ravenscroft, MM; Tweedle, DE | 1 |
| Guslandi, M | 1 |
| Barr, GD; Piper, DW | 1 |
| Bianchi Porro, G; De Nicola, C; Lazzaroni, M; Petrillo, M | 2 |
| Levine, JB | 1 |
| Cantlay, JS; Glover, SC; Mowat, NA; Weir, J | 1 |
| Pounder, RE | 3 |
| Barr, GD; Kellow, JE; Middleton, WR; Piper, DW | 1 |
| Axon, AT; Hamilton, I; O'Connor, HJ; Worsley, BW | 1 |
| Jones, PE; Klass, HJ; Shreeve, DR | 1 |
| Fok, KH; Hui, WM; Koo, J; Lam, SK; Lee, NW; Ng, M | 1 |
| Hameeteman, W; Tytgat, GN; van Olffen, GH | 1 |
| Chakŭrski, I | 2 |
| Backhouse, C; Castro, R; Estela, R; Feller, A; Ugarte, G | 1 |
| Koelz, HR | 1 |
| Ivanov, S; Mateva, L; Matincheva, R | 1 |
| Elina, NA; Grigor'ev, PIa; Iakovenko, EP; Khar'kovskiĭ, NN | 1 |
| Janssens, J; Rutgeerts, P; Schuurmans, P; Vantrappen, G | 1 |
| Hollanders, D; Martin, DF; Miller, JP; Ravenscroft, MM; Tweedle, DE | 1 |
| Axon, AT; Hamilton, I | 1 |
| Murray, JR | 1 |
| Khan, F; Moshal, MG; Spitaels, JM | 2 |
| Broeckaert, L; Janssens, J; Rutgeerts, P; Vantrappen, G | 1 |
| Piper, DW | 1 |
| van Rensburg, W | 1 |
| Cowen, A; Pollard, EJ; Ward, M | 1 |
| Bhoola, R; Khan, F; Moshal, MG; Spitaels, JM; van Leenhoff, H | 1 |
| Alp, MH; Wilson, P | 1 |
| Kang, JY; Piper, DW | 1 |
| Gregory, MA; Moshal, MG; Spitaels, JM | 2 |
| Cowen, A | 1 |
| Alvarez Baleriola, I; Boixeda, D; de Rafael, L; Gisbert, JP; Martín de Argila, C; Vila, T | 1 |
| Alvarez Baleriola, I; Bermejo, F; Boixeda, D; de Rafael, L; García Plaza, A; Gisbert, JP; Martín de Argila, C | 1 |
| Becker, T; Börsch, G; Köhl, H; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B | 1 |
| Colombo, E; Fanti, L; Guslandi, M; Masci, E; Testoni, PA; Tittobello, A | 1 |
| Contreras, L; Giglio, M; Hoffenberg, P; Ossa, P; Reyes, V; Weitz, JC | 1 |
| Forman, D; Harwood, D; Logan, RP; Milne, R; Misiewicz, JJ | 1 |
| Golochevskaia, VS; Grebenev, AL; Lapina, TL; Miagkova, LP; Sklianskaia, OA | 1 |
| Asnicar, MA; Chong, SK; Croffie, JM; Fitzgerald, JF; Lee, CH; Lou, Q; Zimmerman, SE | 1 |
| Fennerty, MB | 1 |
| Beattie, S; Gilvarry, J; Hamilton, H; Keane, CT; O'Morain, CA; Sweeney, EC; Xia, HX | 1 |
| Dehbashi, N; Etaati, H; Fattahi, M; Javan, A; Massarrat, S; Saberi-Firoozi, M; Zare, S | 1 |
| Cheng, AF; Chung, SC; Leung, VK; Li, AK; Ling, TK; Suen, R; Sung, JJ | 1 |
| Coll, I; Espinós, JC; Forné, M; Garau, J; Tresserra, F; Viver, JM | 1 |
| O'Connor, HJ | 1 |
| Clyne, M; Daly, LE; Drumm, B; Durnin, MT; Gormally, SM; Kierce, BM; Prakash, N | 1 |
| Boonyapisit, S; Chinapak, O; Kachintorn, U; Manatsathit, S; Sattawatthamrong, Y; Tanwandee, T | 1 |
| Berstad, A; Wilhelmsen, I | 1 |
| Frazer, NM; Keene, ON; Lacey, LF; Smith, JT | 1 |
| Rune, SJ | 1 |
| Aase, S; Andersen, KJ; Mowinckel, P; Schrumpf, E; Vetvik, K | 1 |
| Banerjee, S; el-Omar, E; McColl, KE | 1 |
| Dhillon, AP; Fraser, AG; Pounder, RE; Sankey, EA; Sim, R | 1 |
| Lee, WY; Lin, JT; Wang, JT; Wang, TH; Wu, MS; Yang, JC | 1 |
| Berstad, A; Berstad, K; Sjödahl, R | 1 |
| al-Assi, MT; Genta, RM; Graham, DY | 1 |
| Corinaldesi, R; De Giorgio, R; Gasperoni, S; Paparo, GF; Poli, L; Stanghellini, V; Tucci, A; Varoli, O | 1 |
| Reilly, TG; Walt, RP | 1 |
| Chang, FY; Chen, TS; Lee, SD; Tsay, SH | 1 |
| Börsch, G; Labenz, J | 2 |
| Brazer, SR; Maniatis, AG | 1 |
| Ammann, R; Bertschinger, P; Casanova, C; Flury, R; Münch, R; Wirth, HP; Wüst, J; Zala, G | 1 |
| Graham, DY; Hazell, SL; Lichtenberger, LM; Ottlecz, A; Romero, JJ | 1 |
| Kihira, K; Kimura, K; Sato, K; Takimoto, T; Taniguchi, Y; Yoshida, Y | 1 |
| Hassall, E; Israel, DM | 1 |
| Börsch, G; Gyenes, E; Labenz, J; Rühl, GH | 1 |
| Calam, J; Moss, SF | 1 |
| Asaka, M; Inoue, K; Kato, M; Kimura, T; Kudo, M; Meguro, T; Miyazaki, T | 1 |
| Axon, AT | 1 |
| Aimo, G; Bonesi, R; Pistoso, S; Piubello, W; Raggi, G; Soldinger, E; Superti, G; Vitali, E | 1 |
| Kanayama, S; Matsuzawa, Y; Nakanishi, T; Shinomura, Y | 1 |
| Genta, RM; Graham, DY; Klein, PD; Lew, GM; Malaty, HM; Ramirez, FC | 1 |
| Cutler, AF; Schubert, TT | 1 |
| Fraser, AG; Hudson, M; Lam, WM; Luk, YW; Pounder, RE; Samloff, IM; Sawyerr, AM; Sercombe, J | 1 |
| Jaskiewicz, K; Louw, JA; Marks, IN | 1 |
| Boixeda, D; Gisbert, JP; Hernández Ranz, F; Martín de Argila, C | 1 |
| Bardhan, KD; Dekkers, CP; Forster, JK; Kler, L; Lacey, LF; Lam, SK; Nowak, A; Schaffalitzky de Muckadell, OB; Schutze, K; Tildesley, G | 1 |
| Bästlein, E; Bayerdörffer, E; Heldwein, W; Höchter, W; Lehn, N; Mannes, GA; Miehlke, S; Müller-Lissner, S; Sommer, A; Weingart, J | 1 |
| Fennerty, MB; Vakil, N | 1 |
| Treiber, G | 1 |
| Davis, S | 1 |
| Laine, LA | 1 |
| Alvarez Baleriola, I; Boixeda, D; de Rafael, L; García Plaza, A; García, M; Gisbert, JP; Martín de Argila, C | 1 |
| Acuña, R; Albornoz, V; Figueroa, G; Portell, DP; Toledo, MS; Troncoso, M; Vigneaux, J | 1 |
| Coyle, W; Dresner, D; Duntemann, T; Lawson, JM; Nemec, R; Peterson, R | 1 |
| Tytgat, GN | 2 |
| Jönsson, B | 1 |
| Bell, GD; Powell, KU | 1 |
| Bermejo, F; Boixeda, D; de Rafael, L; Gisbert, JP; Martín de Argila, C; Redondo, C | 1 |
| Górecka, H; Iwańczak, B; Iwańczak, F; Rajska, H | 1 |
| Ciociola, AA; McSorley, DJ; Peterson, WL; Sykes, DL; Webb, DD | 1 |
| de Boer, WA; Ouwehand, ME; Schade, RW; Schneeberger, PM; Tytgat, GN; van Etten, RJ | 1 |
| Harris, A; Misiewicz, JJ | 1 |
| Bästlein, E; Bayerdörffer, E; Lehn, N; Mannes, GA; Meining, A; Miehlke, S; Stolte, M | 1 |
| Goh, KL; Navaratnam, P; Peh, SC | 1 |
| Axon, AT; Ireland, A; Rooprams, PD; Smith, MJ | 1 |
| Choi, CH; Chung, EC; Kung, NN; Kwok, SP; Li, TH; Lim, BH; Ma, HC; Ng, PW; Sung, JJ; Wong, KC; Yuen, NW | 1 |
| Chan, FK; Chan, LY; Chung, SC; Lee, YT; Leung, WK; Sung, JJ; Yung, MY | 1 |
| Agrawal, BK; Dayal, VM; Kamal, J; Kumar, P; Shahi, SK | 1 |
| Lee, SD; Lin, HJ; Lo, WC; Perng, CL; Wang, K | 1 |
| Hogan, J; Krasner, N; Lombard, M; Purkayastha, SK; Tan, WC | 1 |
| Bardhan, KD; Dallaire, C; Duggan, AE; Eisold, H | 1 |
| Chan, CS; Chan, FK; Chung, SC; Lee, YT; Leung, VK; Li, EK; Sung, JJ; To, KF; Woo, J; Yung, MY | 1 |
| Abdel-Rahman, SM; Nahata, MC; Robinson, DM | 1 |
| Minocha, A; Srinivasan, R | 1 |
| Bielański, W; Bobrzyński, A; Budzyński, A; Gedliczka, O; Konturek, S; Stachura, J | 1 |
| Bardhan, KD; Jahnsen, J; Lotay, N; Marcelino, M; Roberts, PM; Wurzer, H | 1 |
| Scheen, AJ | 1 |
| Breiter, JR; Ciociola, AA; Graham, DY; McSorley, DJ; Sykes, DL | 1 |
| Vondracek, TG | 1 |
| Breslin, NP; O'Morain, C | 1 |
| Bardhan, KD; Blakemore, CB; Cary, BA; Hinchliffe, RF; Morris, P; Singh, S; Thompson, M; Wall, RM | 1 |
| Macri, G; Milani, S; Passaleva, MT; Salvadori, G; Surrenti, C; Surrenti, E | 1 |
| Bazzoli, F; Cardelli, A; Catalano, FA; Giglio, A; Lami, F; Olivieri, A; Pilotto, A; Pozzato, P; Roda, E; Scarpulla, G; Spadaccini, A; Susi, D; Tosatto, R; Zagari, M | 1 |
| Crobach, LF; Geraedts, AA; Kolkman, JJ; Nicolai, JJ; Oudkerk Pool, M; Tan, TG; Timmerman, RJ; Van Der Laan, J; Van Kleef, WA; Wolff, AA | 1 |
| Bashirova, ES; Butorov, IL; Darvin, VV; Lokhvitskiĭ, SV; Proshin, AV | 1 |
| Di Matteo, G; Dobrilla, G; Dodero, M; Fina, P; Fratton, A; Iaquinto, G; Loriga, P; Marchi, S; Marzio, L; Muratori, R; Olivieri, A; Pacini, D; Saggioro, A; Savarino, V; Spinelli, P; Tosatto, R; Zamboni, G | 1 |
| Bentivegna, C; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R; Condorelli, G | 1 |
| Butruk, E; Dziurkowska-Marek, A; Hennig, E; Kohut, M; Marek, T; Nowak, A; Ostrowski, J; Przytulski, K; Regula, J | 1 |
| Chan, FK; Cheng, AF; Chung, SC; Lee, YT; Leung, WK; Ling, TK; Sung, JJ; Yung, MY | 1 |
| Ciociola, AA; Heath, A; Lanza, FL; McSorley, DJ; Sontag, SJ; Sykes, DL | 1 |
| Kashifard, M; Malekzadeh, R; Massarrat, S; Mikaeli, J; Siavoshi, F | 1 |
| Chang, MH; Hsu, HY; Huang, FC; Lee, PI; Shun, CT | 1 |
| Chua, AB; Cutler, A; Ding, RP; Goh, KL; Kandasami, P; Mazlam, MZ; Raj, SM | 1 |
| Kabala, A; Pawłowski, W; Petsch, B | 1 |
| Kleibeuker, JH; Kooy, A; Thijs, JC; Van der Wouden, EJ; Zwet, AA | 1 |
| Marshall, JB | 1 |
| Dai, S; Du, H; Li, Q; Li, Y; Nie, Y; Sha, W; Wang, H; Wu, H | 1 |
| Khan, F; Mason, J; Moshal, MG; Naidoo, V; Schlemmer, L; Spitaels, JM | 1 |
| Axon, A | 1 |
| Mach, T; Zahradnik-Bilska, J | 1 |
| Borda, F; Domínguez, E; Gisbert, JP; Sainz, R | 1 |
| Chey, WD; Chien, NN; Chung, NQ; Connor, BA; Henley, KS; Hoan, PQ; Hop, TV; Lak, BV; Long, T; Mao, HV; Perez-Perez, GI; Stone, CD; Thang, DM | 1 |
| Ballardini, G; Boni, F; Bortoli, A; Colombo, E; Minoli, G; Spinzi, GC; Venturelli, R | 1 |
| Barkun, AN; Beech, R; Best, L; Fallone, CA; Friedman, G; Joseph, L; Loo, V; Mayrand, S | 1 |
| Buzás György, M; Illyés, G; Székely, E; Széles, I | 1 |
| Ching, CK; Hu, WH; Hui, WM; Lai, KC; Lam, SK; Wong, BC; Wong, WM | 1 |
| Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R | 1 |
| Mégraud, F; Roberts, P; Williamson, R | 1 |
| Belmonte, A; Cavaliere, C; Ciliberto, E; Fiocca, R; Frandina, C; Giglio, A; Luzza, F; Pallone, F; Saccà, N; Trimboli, V | 1 |
| Hopkins, RJ | 1 |
| Dixon, CA; Hopkins, RJ; Meyer, JM; Siepman, NY; Silliman, NP; Sugg, JE | 1 |
| Ananthakrishnan, N; Badrinath, S; Kate, V | 1 |
| Doulgeroglou, V; Kamberoglou, D; Patra, E; Polymeros, D; Sanidas, I; Savva, S; Tzias, V | 1 |
| Dudik, TV; Il'chenko, AA; Kaprel'yants, AS; Loginov, AS; Reshetnyak, VI; Vostroknutova, GN | 1 |
| Langman, MJ | 3 |
| Gregory, MA; Moshal, MG; Pillay, C; Spitaels, JM | 1 |
| Alp, MH; Coughlin, GP; Kupa, A | 1 |
| Connon, JJ | 1 |
| Lee, SP; Nicholson, GI | 1 |
| Bank, S; Barbezat, GO; Mekel, RC; Novis, BH; Serfontein, WJ | 1 |
| Dekker, W; Reisma, K | 1 |
| Bozhiianov, V; Brailski, KH; Kadiian, KH | 1 |
| Moshal, MG | 3 |
| Shreeve, DR | 1 |
| Avery, GS; Brogden, RN; Pinder, RM; Sawyer, PR; Speight, TM | 1 |
| Karaagac, M; Ozman, M; Sezer, R | 1 |
| Bär, W; Freise, J; Gebel, M; Gladziwa, U; Haruma, K; Lange, P; Schmidt, FW; Wagner, S | 1 |
| Isenberg, JI; McQuaid, KR | 1 |
| Cheng, A; Chung, SC; Hosking, SW; Leung, JW; Li, AK; Ling, TK; Yung, MY | 1 |
| Jaskiewicz, K; Lastovica, A; Le Roux, E; Louw, JA; Lucke, W; Marks, IN; Winter, T; Zak, J | 1 |
| Chai, JY; Gu, MS; Kim, NY; Kim, SY; Kook, J; Lee, KH; Lee, SH; Park, SH | 1 |
| Corbishley, CM; Goggin, PM; Jackson, PA; Marrero, JM; Northfield, TC; Spychal, RT | 1 |
| Berstad, A; Berstad, K; Hundal, O; Wilhelmsen, I | 1 |
| Bell, GD; Bolton, G; Brooks, S; Burridge, SM; Gant, PW; Harrison, G; Powell, KU; Prosser, S; Purser, K; Spencer, G | 1 |
| Bessonova, GA; Geller, LI | 1 |
| Ahmed, A; Cairns, CR; Hobsley, M; Hoult, JR; Salmon, PR | 1 |
| Beattie, S; Keane, C; O'Morain, C; Patchett, S | 1 |
| Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM; Malaty, HM; Saeed, ZA | 1 |
| Hellström, PM | 1 |
| Alpert, LC; Evans, DG; Evans, DJ; Genta, RM; Graham, DY; Klein, PD; Lew, GM; Malaty, HM | 1 |
| Chittajalu, R; Dahill, SW; el Nujumi, AM; Fullarton, GM; Hilditch, TE; MacDonald, AM; McColl, KE | 1 |
| Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM | 1 |
| Ali, MR; Brown, P; Hamilton, I; Lane, M; Morris, A; Nicholson, G; Samarasinghe, D | 1 |
| Lee, FD; Nakshabendi, IM; Peebles, SE; Russell, RI | 1 |
| Bianchi Porro, G; Parente, F | 1 |
| Beker, JA; Koek, GH | 1 |
| Colimon, R; Flourié, B; Lavergne, A; Mignon, M; Modigliani, R; Rambaud, JC; Sobhani, I | 1 |
| Dunk, AA; Mowat, NA; O'Morain, C; Prabhu, U; Tobin, A | 1 |
| Keane, C; Mathai, E; McKenna, D; O'Morain, C; O'Riordan, T; Sweeney, E; Tobin, E | 1 |
| Korman, MG | 1 |
| Loffeld, RJ | 1 |
| Annibale, B; Corleto, V; de Magistris, L; Delle Fave, G; Giordano, E; Puoti, M; Torsoli, A | 1 |
| Islam, S; McLean, AJ | 1 |
| Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM; Opekun, A | 1 |
| Leiss, O | 1 |
| Bianchi Porro, G; Lazzaroni, M; Petrillo, M | 1 |
| Bayerdörffer, E; Mannes, GA; Pfaller, P; Sauerbruch, T | 1 |
| Chiverton, SG; Hunt, RH; Veuldhuyzen van Zanten, SJ | 1 |
| Bajza, Y; Figus, AI; Papp, I | 1 |
| Holt, KM; Isenberg, JI | 1 |
| Hardman, M; Lee, FI; Samloff, IM | 1 |
| Blum, AL | 1 |
| Hunt, RH; Jones, DB | 1 |
| Bianchi Porro, G; Lazzaroni, M; Pace, F; Parente, F | 1 |
| Bästlein, C; Bayerdörffer, E; Kasper, G; Ottenjann, R; Simon, T | 1 |
| Bianchi Porro, G; Lazzaroni, M | 1 |
| Bell, B; Goodwin, CS; McCullough, C; Turner, M | 1 |
| Tyszkiewicz, T | 1 |
| Dettmer, A; Eberhardt, R; Hagena, D; Höchter, W; Kasper, G | 1 |
| Menge, H | 1 |
| Colin-Jones, DG | 1 |
| Baron, JH; Barr, J; Batten, J; Sidebotham, R; Spencer, J | 1 |
| Faragher, EB; Miller, JP | 1 |
| Börsch, G; Mai, U; Müller, KM | 1 |
| Chiasson, D; Cutz, E; Drumm, B; Karmali, M; Sherman, P | 1 |
| Weller, MP | 1 |
| Bianchi Porro, G; Cortvriendt, WR; Lazzaroni, M | 1 |
| Axon, AT; Bradbury, I; Hamilton, I; O'Connor, HJ; Wood, NC | 1 |
| Marshall, BJ | 1 |
| Armstrong, JA; Goodwin, CS; Marshall, BJ | 1 |
| Cowen, AE; Halliday, C; Ward, M | 1 |
| Elder, JB | 1 |
| Bianchi Porro, B; Lazzaroni, M; Parente, F; Petrillo, M | 1 |
| Barbara, L; Corinaldesi, R; Paternicò, A; Rea, E; Stanghellini, V | 1 |
| Bianchi Porro, G; Boekhorst, JC; Crowe, JP; Dal Monte, PR; Dekker, W; Robinson, TJ; Thys, O; Van Bentem, N; Van Driel, A | 1 |
| Bianchi Porro, G; Lazzaroni, M; Parente, F; Prada, A | 1 |
| Ceglarski, Z; Knapik, Z; Lubczyńska-Kowalska, W; Paradowski, L; Sekowska, E | 1 |
| Hollanders, D | 1 |
| Carr-Locke, D; Wicks, AB | 1 |
| Rösch, W | 1 |
| Dudley, FJ; McCarthy, P; McLean, AJ | 1 |
| Lam, SK | 1 |
| Lane, M; Lee, S; Nicholson, G; Tasman-Jones, C | 1 |
| Demin, AA; Lebedev, VP | 1 |
| Kassir, ZA | 1 |
| Golovanova, ES; Syman, LN; Tsimmerman, IaS | 1 |
| Hudson, HM; McIntosh, JH; Piper, DW | 1 |
| Boyd, E; Marks, IN | 1 |
| Benyon, JS | 1 |
| Bergoz, R | 1 |
| Bouillon, M; Camatte, R; Gauthier, AP; Sarles, H | 1 |
| Bartenschlager, HM | 1 |
| Brown, P; Read, AE; Salmon, PR; Williams, R | 1 |
| Bourdais, JP; Hureau, J | 1 |
| Camatte, R; Fouilloux, C; Sarles, H | 1 |
| Arias Vallejo, E; Conesa Picó, O; Güemes Díaz, F; Hidalgo, H | 1 |
| Cruickshank, GW; Wright, T | 1 |
| Berndt, H; Gütz, HJ; Jacobasch, KH; Prahl, B; Wolff, G | 1 |
| Serfontein, WJ; Weiss, G | 1 |
| Chernov, AP | 1 |
| Theinl, K | 1 |
35 review(s) available for bismuth and Duodenal Ulcer
| Article | Year |
|---|---|
[Bismuth preparations in the treatment of patients with gastric and duodenal ulcer disease].
Topics: Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Humans; Intestinal Mucosa; Organometallic Compounds; Stomach Ulcer; Treatment Outcome | 2008 |
Is it time for quadruple therapy to be first line?
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Time Factors | 2003 |
Medical management of peptic ulcer.
Topics: Aluminum; Antacids; Benzimidazoles; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Humans; Omeprazole; Parasympatholytics; Ranitidine; Recurrence; Stomach Ulcer; Sucralfate; Time Factors | 1984 |
Pharmacologic options for the control of peptic ulcer disease.
Topics: Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Omeprazole; Parasympatholytics; Peptic Ulcer; Prostaglandins, Synthetic; Ranitidine; Risk; Stomach Neoplasms; Surface-Active Agents | 1984 |
Sucralfate, bismuth compounds, substituted benzimidazoles, trimipramine and pirenzepine in the short- and long-term treatment of duodenal ulcer.
Topics: Aluminum; Animals; Antacids; Anti-Ulcer Agents; Benzimidazoles; Benzodiazepinones; Bismuth; Clinical Trials as Topic; Dibenzazepines; Duodenal Ulcer; Humans; Pirenzepine; Recurrence; Sucralfate; Time Factors; Trimipramine | 1984 |
The treatment of chronic peptic ulcer.
Topics: Antacids; Bismuth; Carbenoxolone; Chronic Disease; Cimetidine; Duodenal Ulcer; Evaluation Studies as Topic; Gastrectomy; Hospitalization; Humans; Stomach Ulcer; Vagotomy | 1980 |
Eradication of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Benzimidazoles; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Recurrence; Stomach Neoplasms; Stomach Ulcer | 1994 |
Treatment strategies for symptom resolution, healing, and Helicobacter pylori eradication in duodenal ulcer patients.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Tinidazole | 1994 |
Duodenal ulcer treatment: progress from pH to HP.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Tetracycline | 1994 |
Helicobacter pylori infection.
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Stomach Neoplasms; Stomach Ulcer; Tetracycline | 1993 |
The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Imidazoles; Omeprazole; Penicillins; Regression Analysis; Stomach Ulcer; Tetracycline; Time Factors | 1996 |
Triple therapy and Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Stomach Neoplasms; Stomach Ulcer; Tetracycline; Time Factors | 1996 |
Helicobacter pylori and complicated ulcer disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer Hemorrhage; Risk Factors; Stomach Ulcer | 1996 |
Current indications for Helicobacter pylori eradication therapy.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Stomach Neoplasms; Stomach Ulcer | 1996 |
New developments in Helicobacter pylori eradication therapy.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine | 1997 |
Guidelines for the treatment of Helicobacter pylori in the pediatric population.
Topics: Adolescent; Amoxicillin; Bismuth; Child; Child, Preschool; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Infant; Tinidazole | 1997 |
Ranitidine bismuth citrate in the treatment of Helicobacter pylori infection and duodenal ulcer.
Topics: Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Drug Interactions; Duodenal Ulcer; Formularies as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Ranitidine | 1998 |
[A consensus on some problems of Helicobacter pylori (draft)].
Topics: Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Stomach Ulcer | 1997 |
[Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Duodenitis; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lymphoma, B-Cell, Marginal Zone; Organometallic Compounds; Penicillins; Proton Pump Inhibitors; Ranitidine; Stomach Neoplasms; Stomach Ulcer | 1999 |
Helicobacter pylori and early duodenal ulcer status post-treatment: a review.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Humans; Lansoprazole; Odds Ratio; Omeprazole; Ranitidine; Research Design; Retrospective Studies; United States; United States Food and Drug Administration | 2001 |
Drugs in the treatment of gastric and duodenal ulcer.
Topics: Amylopectin; Antacids; Bismuth; Carbenoxolone; Cholestyramine Resin; Duodenal Ulcer; Estrogens; Fatty Acids, Unsaturated; Glycyrrhiza; Histamine H2 Antagonists; Humans; Imidazoles; Metoclopramide; Parasympatholytics; Plants, Medicinal; Prostaglandins, Synthetic; Recurrence; Stomach Ulcer; Zinc | 1977 |
Medical treatment of duodenal ulcer.
Topics: Antacids; Bismuth; Carbenoxolone; Cimetidine; Citrates; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation; Duodenal Ulcer; Humans; Placebos; Recurrence; Time Factors | 1979 |
Medical therapy of peptic ulcer disease.
Topics: Antacids; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Diet; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Omeprazole; Stomach Ulcer | 1992 |
[High demands on drug administration and pharmacological principles applied in ulcer diseases].
Topics: Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Omeprazole; Prostaglandins; Receptors, Muscarinic; Stomach Ulcer; Sucralfate | 1991 |
Site-and cytoprotective drugs in the short-term treatment of peptic ulcer. What is their current role?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Duodenal Ulcer; Gastric Mucosa; Helicobacter pylori; Histamine H2 Antagonists; Humans; Organometallic Compounds; Smoking; Stomach Ulcer | 1990 |
[Helicobacter pylori and gastroduodenal pathology. Second part: Clinical aspects and therapy].
Topics: Achlorhydria; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Stomach Ulcer | 1991 |
Helicobacter pylori: fact or fiction?
Topics: Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Prevalence | 1990 |
[Current perspectives in the pathogenesis and the treatment of duodenal ulcer].
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Helicobacter pylori; Humans | 1990 |
Therapeutic approach to ulcer healing.
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Antidepressive Agents; Benzodiazepinones; Bismuth; Colloids; Drug Administration Schedule; Duodenal Ulcer; Duodenoscopy; Histamine H2 Antagonists; Humans; Peptic Ulcer; Pirenzepine; Recurrence; Stomach Ulcer; Sucralfate | 1985 |
[What is safe in the treatment of Campylobacter pylori-induced gastritis and Campylobacter pylori-associated peptic ulcer?].
Topics: Amoxicillin; Bismuth; Campylobacter; Campylobacter Infections; Cimetidine; Duodenal Ulcer; Gastritis; Humans; Stomach Ulcer | 1988 |
There is more to healing ulcers than suppressing acid.
Topics: Aluminum; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Gastric Acid; Humans; Organometallic Compounds; Pepsin A; Peptic Ulcer; Prostaglandins; Sucralfate | 1986 |
Campylobacter pyloridis, gastritis, and peptic ulceration.
Topics: Amoxicillin; Animals; Anti-Ulcer Agents; Antibodies, Bacterial; Bismuth; Campylobacter; Campylobacter Infections; Duodenal Ulcer; Escherichia coli Infections; Female; Gastric Mucosa; Gastritis; Humans; Male; Microscopy, Electron; Middle Aged; Organometallic Compounds; Rabbits; Stomach Ulcer | 1986 |
Recent experimental and clinical studies on the pharmacology of colloidal bismuth subcitrate.
Topics: Animals; Bismuth; Campylobacter; Dinoprostone; Duodenal Ulcer; Gastric Mucosa; Gastritis; Humans; Organometallic Compounds; Prostaglandins E | 1986 |
The influence of colloidal bismuth subcitrate on duodenal ulcer relapse.
Topics: Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Humans; Organometallic Compounds; Recurrence | 1986 |
The role of colloidal bismuth subcitrate in the short-term treatment of duodenal ulcer.
Topics: Bismuth; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Humans; Organometallic Compounds; Ranitidine | 1986 |
144 trial(s) available for bismuth and Duodenal Ulcer
| Article | Year |
|---|---|
[The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease].
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Prospective Studies; Russia; Stomach Ulcer | 2019 |
New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese pro
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Capsules; China; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Tetracycline; Young Adult | 2018 |
Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Tetracycline | 2018 |
[Quadruple regimens using domestically manufactured drugs in gastritis and duodenal ulcer patients for Helicobacter pylori eradication: a perspective, multicenter, randomized controlled trial].
Topics: Amoxicillin; Antacids; Bismuth; Breath Tests; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Urea | 2016 |
A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Middle Aged; Organometallic Compounds; Pantoprazole | 2012 |
One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Penicillins; Ranitidine; Treatment Outcome | 2002 |
Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate.
Topics: Adolescent; Adult; Aged; Bismuth; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Guanidines; Humans; Male; Middle Aged; Organometallic Compounds; Random Allocation; Recurrence; Time Factors; Wound Healing | 1981 |
Relapse rates in duodenal ulcer patients formerly treated with bismuth subcitrate or maintained with cimetidine.
Topics: Adult; Antacids; Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Follow-Up Studies; Humans; Male; Middle Aged; Organometallic Compounds; Recurrence | 1984 |
Oral tripotassium-dicitratobismuthate in gastric and duodenal ulceration. A double-blind controlled trial.
Topics: Adult; Aged; Bismuth; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds; Palliative Care; Peptic Ulcer; Prospective Studies; Random Allocation; Stomach Ulcer | 1983 |
Comparison of colloidal bismuth subcitrate tablets and liquid in duodenal ulcer healing.
Topics: Adult; Aged; Analgesics; Antacids; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Colloids; Double-Blind Method; Duodenal Ulcer; Humans; Middle Aged; Organometallic Compounds; Smoking; Tablets | 1983 |
Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.
Topics: Adult; Aged; Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Gastric Acidity Determination; Gastric Juice; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Organometallic Compounds; Stomach; Tablets | 1983 |
Comparison of cimetidine and tripotassium dicitrato bismuthate in healing and relapse of duodenal ulcers.
Topics: Adolescent; Adult; Age Factors; Aged; Bismuth; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Organometallic Compounds; Random Allocation; Recurrence; Time Factors; Wound Healing | 1983 |
Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Drug Resistance; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds; Random Allocation; Tablets | 1984 |
Sucralfate, bismuth compounds, substituted benzimidazoles, trimipramine and pirenzepine in the short- and long-term treatment of duodenal ulcer.
Topics: Aluminum; Animals; Antacids; Anti-Ulcer Agents; Benzimidazoles; Benzodiazepinones; Bismuth; Clinical Trials as Topic; Dibenzazepines; Duodenal Ulcer; Humans; Pirenzepine; Recurrence; Sucralfate; Time Factors; Trimipramine | 1984 |
[Comparative studies of the therapeutic effect of a herbazol preparation with and without an antacid component in duodenal peptic ulcer patients].
Topics: Antacids; Bicarbonates; Bismuth; Clinical Trials as Topic; Drug Combinations; Duodenal Ulcer; Gastric Acid; Humans; Magnesium; Placebos; Plant Extracts; Sodium Bicarbonate; Tablets; Time Factors | 1984 |
A double-blind endoscopic study with De-Nol tablets and cimetidine for duodenal ulcer.
Topics: Adult; Bismuth; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Tablets | 1984 |
[Effects of colloidal bismuth subcitrate and aluminum hydroxide on gastric and duodenal levels of prostaglandin E2].
Topics: Adult; Aluminum Hydroxide; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Dinoprostone; Double-Blind Method; Duodenal Ulcer; Duodenum; Female; Gastric Acid; Gastric Mucosa; Humans; Intestinal Mucosa; Male; Middle Aged; Organometallic Compounds; Prostaglandins E | 1984 |
[Treatment of duodenal ulcer with herbazol].
Topics: Antacids; Anti-Ulcer Agents; Bicarbonates; Bismuth; Cimetidine; Drug Combinations; Drug Evaluation; Duodenal Ulcer; Humans; Magnesium; Placebos; Plant Extracts; Sodium Bicarbonate; Tablets; Time Factors | 1984 |
A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer.
Topics: Adult; Aged; Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Endoscopy; Female; Follow-Up Studies; Guanidines; Humans; Male; Middle Aged; Organometallic Compounds; Recurrence; Time Factors | 1982 |
Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
Topics: Adolescent; Adult; Aged; Antacids; Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Guanidines; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Recurrence; Time Factors | 1982 |
Present and future treatment of peptic ulcer and potential role of DE-NOL.
Topics: Antacids; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Disease Models, Animal; Duodenal Ulcer; Gastrointestinal Hemorrhage; Humans; Organometallic Compounds; Peptic Ulcer; Recurrence; Stomach Ulcer | 1982 |
Controlled trial comparing De-Nol tablets with De-Nol liquid in treatment of duodenal ulcer.
Topics: Adult; Aged; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds; Tablets | 1981 |
Bicitropeptide and cimetidine in the treatment of duodenal ulcers. A double-blind, double-dummy endoscopically controlled trial.
Topics: Adult; Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Guanidines; Humans; Metalloproteins; Proteins | 1980 |
Randomised open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer.
Topics: Adult; Bismuth; Cimetidine; Clinical Trials as Topic; Colloids; Duodenal Ulcer; Female; Guanidines; Humans; Male; Middle Aged; Random Allocation | 1980 |
Bicitropeptide and cimetidine in the treatment of duodenal ulcers.
Topics: Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Guanidines; Humans; Metalloproteins; Proteins; Random Allocation | 1981 |
Double-blind trial of cimetidine versus tri-potassium di-citrato bismuthate in chronic duodenal ulceration.
Topics: Adult; Aged; Alcohol Drinking; Anti-Ulcer Agents; Bismuth; Chronic Disease; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Guanidines; Humans; Male; Middle Aged; Organometallic Compounds; Smoking | 1981 |
Tri-potassium di citrato bismuthate chewing tablets and cimetidine tablets in the treatment of duodenal ulcers. A double-blind double-dummy comparative study.
Topics: Adult; Bismuth; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Guanidines; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Random Allocation; Smoking; Time Factors | 1981 |
Bicitropeptide powder and placebo in the treatment of duodenal ulcers. A double-blind endoscopically controlled clinical trial.
Topics: Adult; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Humans; Metalloproteins; Proteins | 1982 |
Colloidal bismuth subcitrate tablets and placebo in chronic duodenal ulceration: a double-blind, randomised trial.
Topics: Adult; Aged; Bismuth; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Endoscopy; Female; Humans; Male; Middle Aged; Organometallic Compounds; Random Allocation; Tablets | 1982 |
Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer. Comparison of initial healing and recurrence after healing.
Topics: Bismuth; Cimetidine; Clinical Trials as Topic; Colloids; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Follow-Up Studies; Gastrointestinal Hemorrhage; Guanidines; Humans; Middle Aged; Recurrence | 1982 |
Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Outcome | 1995 |
Colloid bismuth versus famotidine in the treatment and prevention of duodenal ulcer relapse: results of a double-blind, double dummy randomized study.
Topics: Antacids; Anti-Ulcer Agents; Bismuth; Colloids; Double-Blind Method; Duodenal Ulcer; Endoscopy, Gastrointestinal; Famotidine; Helicobacter pylori; Humans; Recurrence | 1995 |
[Comparison of 2 treatment schemes to eradicate Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Recurrence | 1995 |
Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Prospective Studies; Recurrence; Tetracycline; Time Factors | 1995 |
Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized
Topics: Adult; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Nitrates; Omeprazole; Prospective Studies; Ranitidine; Recurrence; Tetracycline; Time Factors; Tinidazole | 1995 |
Triple therapy with sucralfate, tetracycline, and metronidazole for Helicobacter pylori-associated duodenal ulcers.
Topics: Adult; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Sucralfate; Tetracycline | 1995 |
Impact of colloidal bismuth subnitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study.
Topics: Antacids; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 1995 |
Association of symptoms with Helicobacter pylori infection in children.
Topics: Adolescent; Biopsy; Bismuth; Child; Chronic Disease; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Duodenum; Female; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Prospective Studies | 1995 |
Effects of cigarette smoking on duodenal ulcer healing and relapse rate.
Topics: Adolescent; Adult; Aged; Bismuth; Cimetidine; Colloids; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Recurrence; Smoking; Sucralfate; Treatment Outcome | 1994 |
Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Antacids; Bismuth; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Oxytetracycline; Prospective Studies; Quality of Life; Recurrence; Severity of Illness Index; Time Factors | 1994 |
Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
Topics: Adolescent; Adult; Anti-Ulcer Agents; Bismuth; Citrates; Double-Blind Method; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine | 1994 |
Effects of omeprazole and eradication of Helicobacter pylori on gastric and duodenal mucosal enzyme activities and DNA in duodenal ulcer patients.
Topics: Antacids; Biopsy; Bismuth; DNA; Drug Therapy, Combination; Duodenal Ulcer; Duodenum; Female; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Male; Metronidazole; Middle Aged; Omeprazole; Oxytetracycline; Stomach | 1994 |
Prospective, randomized study of H2-blocker and triple therapy for duodenal ulcer treatment and the eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence | 1994 |
Short report: omeprazole-tetracycline combinations are inadequate as therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Stomach Ulcer; Tetracycline | 1994 |
Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Time Factors | 1994 |
[The effect of the eradication of H. pylori on the intractable ulcer].
Topics: Ampicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Recurrence | 1993 |
Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth.
Topics: Adult; Aged; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Stomach Ulcer; Tetracycline | 1993 |
Patient factors affecting Helicobacter pylori eradication with triple therapy.
Topics: Adult; Age Factors; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Marriage; Metronidazole; Middle Aged; Multivariate Analysis; Patient Compliance; Prospective Studies; Recurrence; Stomach Ulcer; Tetracycline | 1993 |
Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens.
Topics: Adult; Aged; Bismuth; Breath Tests; Citrates; Duodenal Ulcer; Food; Gastrins; Humans; Male; Middle Aged; Organometallic Compounds; Pepsinogens; Ranitidine; Time Factors | 1993 |
GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer.
Topics: Adult; Bismuth; Dose-Response Relationship, Drug; Double-Blind Method; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Logistic Models; Male; Middle Aged; Ranitidine; Treatment Outcome | 1995 |
Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Penicillins; Recurrence; Salicylates | 1995 |
Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Chile; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Recurrence; Salicylates; Single-Blind Method; Time Factors | 1996 |
Efficacy of ciprofloxacin in the eradication of Helicobacter pylori.
Topics: Adult; Aged; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies | 1996 |
Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Patient Compliance; Ranitidine; Recurrence | 1996 |
4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Premedication; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Time Factors | 1996 |
Reinfection and duodenal ulcer relapse in south-east Asian patients following successful Helicobacter pylori eradication: results of a 2-year follow-up.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Recurrence; Time Factors | 1996 |
Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Patient Compliance; Ranitidine | 1997 |
Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Topics: Activities of Daily Living; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hospitalization; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer Hemorrhage; Stomach Ulcer; Tetracycline | 1997 |
Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Nizatidine; Omeprazole; Organometallic Compounds; Penicillins; Ranitidine; Salicylates | 1997 |
Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Treatment Outcome | 1997 |
Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Life Tables; Male; Middle Aged; Ranitidine; Treatment Outcome; Wound Healing | 1997 |
Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Drug Administration Schedule; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Naproxen; Organometallic Compounds; Prospective Studies; Stomach Ulcer; Tetracycline | 1997 |
[Hormonal changes and secretion and stomach mucosal microstructure in the course of H. pylori in patients with duodenal ulcer].
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Epidermal Growth Factor; Gastric Juice; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Somatostatin | 1997 |
Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitrichomonal Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome | 1998 |
An alternative non-macrolide, non-imidazole treatment regimen for curing Helicobacter pylori and duodenal ulcers: ranitidine bismuth citrate plus amoxicillin. The RBC H. pylori Study Group.
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Bismuth; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Time Factors | 1998 |
Maintenance therapy with colloidal bismuth subcitrate reduces duodenal ulcer relapse.
Topics: Adult; Aged; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Double-Blind Method; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine; Recurrence | 1997 |
Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long-term follow-up study.
Topics: Adult; Amoxicillin; Antacids; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer Hemorrhage; Prospective Studies; Recurrence | 1998 |
Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine | 1998 |
Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Wound Healing | 1997 |
Ranitidine bismuth citrate with either clarithromycin 1 g/day or 1.5 g/day is equally effective in the eradication of H. pylori and healing of duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Child, Preschool; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine | 1998 |
Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Protocols; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Single-Blind Method | 1998 |
Randomized comparison of 1-hour topical method vs. amoxycillin plus omeprazole for eradication of Helicobacter pylori in duodenal ulcer patients.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clinical Protocols; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Humans; Intubation, Gastrointestinal; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pronase; Ranitidine | 1998 |
One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Combined Modality Therapy; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pumps; Ranitidine; Single-Blind Method; Treatment Outcome | 1998 |
Ranitidine bismuth citrate plus clarithromycin: a dual therapy regimen for patients with duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine; Recurrence; Treatment Outcome | 1998 |
Continuous and more effective duodenal ulcer healing under therapy with bismuth and two antibiotics than with dual therapy comprising omeprazole and amoxicillin.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Duodenum; Female; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Tetracycline; Treatment Outcome | 1998 |
[The treatment of chronic duodenal ulcer with accompanying Helicobacter pylori infection].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Clinical Protocols; Duodenal Ulcer; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Penicillins; Ranitidine; Retrospective Studies; Treatment Outcome | 1998 |
The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Penicillins; Ranitidine; Stomach Ulcer | 1999 |
Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori--positive duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; China; Colloids; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pectins | 1999 |
Factors affecting duodenal ulcer healing. Four double-blind trials in 193 patients.
Topics: Adult; Alcohol Drinking; Anti-Ulcer Agents; Bismuth; Cimetidine; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Metalloproteins; Placebos; Proteins; Ranitidine; Smoking; Sucralfate | 1982 |
[Reinfection with Helicobacter pylori in patients with duodenal ulcer after successful eradication].
Topics: Adult; Amoxicillin; Bismuth; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Wound Healing | 1999 |
Omeprazole or ranitidine bismuth citrate triple therapy to treat Helicobacter pylori infection: a randomized, controlled trial in Vietnamese patients with duodenal ulcer.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Bismuth; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin A; Male; Middle Aged; Omeprazole; Patient Compliance; Ranitidine; Urease; Vietnam | 2000 |
Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Prospective Studies; Ranitidine; Single-Blind Method | 2000 |
Is Helicobacter pylori eradication associated with gastroesophageal reflux disease?
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Esophagitis, Peptic; Female; Follow-Up Studies; Gastroesophageal Reflux; Gastroscopy; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Treatment Failure | 2000 |
[Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Treatment Outcome | 2000 |
Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage--a long-term randomized, controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Male; Metronidazole; Middle Aged; Peptic Ulcer Hemorrhage; Prognosis; Secondary Prevention | 2000 |
Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Costs and Cost Analysis; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2000 |
Ranitidine bismuth citrate can help to overcome Helicobacter pylori resistance to clarithromycin in vivo.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Synergism; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine | 2000 |
Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Headache; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pruritus; Ranitidine; Recurrence; Taste Disorders; Tinidazole; Treatment Outcome | 2001 |
Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: retrospective and prospective randomized controlled studies.
Topics: Adolescent; Adult; Aged; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer Perforation; Prospective Studies; Ranitidine; Recurrence; Retrospective Studies; Tetracycline | 2001 |
Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome | 2001 |
The effect of tri-potassium di-citrato bismuthate (De-Nol) on the healing of chronic duodenal ulcers.
Topics: Adult; Bismuth; Chronic Disease; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Placebos; Wound Healing | 1977 |
Denol, an effective drug in the therapy of duodenal ulceration.
Topics: Adult; Bismuth; Citrates; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male | 1977 |
Increased healing of gastric and duodenal ulcers in a controlled trial using tripotassium dicitrato-bismuthate.
Topics: Adult; Aged; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Endoscopy; Female; Humans; Male; Middle Aged; Placebos; Stomach Ulcer | 1977 |
Bicitropeptide, antacid and placebo in gastric and duodenal ulceration. A two-centre, double-blind, comparative endoscopic study.
Topics: Adult; Antacids; Bismuth; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Duodenal Ulcer; Female; Humans; Male; Peptic Ulcer; Placebos; Proteins | 1979 |
Medical treatment of duodenal ulcer.
Topics: Antacids; Bismuth; Carbenoxolone; Cimetidine; Citrates; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation; Duodenal Ulcer; Humans; Placebos; Recurrence; Time Factors | 1979 |
Double-blind controlled trial with colloidal bismuth subcitrate in the treatment of symptomatic duodenal ulcers with special references to blood and urine bismuth levels.
Topics: Adult; Aged; Bismuth; Clinical Trials as Topic; Colloids; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Placebos | 1979 |
[Clinical trial of the preparation Caved S in treating peptic ulcer].
Topics: Adult; Aluminum Hydroxide; Antacids; Bismuth; Bulgaria; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Duodenal Ulcer; Female; Glycyrrhiza; Humans; Male; Middle Aged; Peptic Ulcer; Plants, Medicinal; Stomach Ulcer; Tablets | 1975 |
Endoscopic evaluation of the effect of Ulcerone and placebo on duodenal ulcers.
Topics: Adult; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Duodenum; Endoscopy; Female; Humans; Male; Wound Healing | 1976 |
The treatment of duodenal ulcers with TDB: a duodenoscopic double-blind cross-over investigation.
Topics: Adult; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Placebos | 1975 |
A double-blind study of tri-potassium di-citrato bismuthate in doudenal ulcer.
Topics: Adolescent; Adult; Aged; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Placebos | 1975 |
A bismuth-peptide complex in the treatment of duodenal ulceration. A double-blind duodenoscopic study.
Topics: Adolescent; Adult; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Endoscopy; Female; Gastric Juice; Humans; Male; Middle Aged; Pentagastrin; Peptides; Placebos; Secretory Rate; Stimulation, Chemical; Time Factors | 1975 |
Clinical, radiological and laboratory findings in patients with duodenal ulcer, treated with micronized bismuth subnitrate, singly and in combination with antacids.
Topics: Adolescent; Adult; Antacids; Bismuth; Duodenal Ulcer; Female; Gastric Acidity Determination; Gastroscopy; Humans; Male; Middle Aged; Particle Size; Pepsinogens; Radiography | 1975 |
Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori.
Topics: Bismuth; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine; Salicylates; Time Factors | 1992 |
Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer.
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Duodenum; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Single-Blind Method; Tetracycline | 1992 |
Triple therapy with sucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reducing duodenal ulcer relapse rates.
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Prospective Studies; Recurrence; Risk Factors; Sucralfate; Tetracycline | 1992 |
Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: effect of clearance and eradication.
Topics: Adult; Aged; Amoxicillin; Analysis of Variance; Bismuth; Duodenal Ulcer; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Longitudinal Studies; Male; Metronidazole; Middle Aged; Ranitidine; Recurrence; Regression Analysis; Water | 1992 |
Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori.
Topics: Adult; Aged; Bismuth; Circadian Rhythm; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Erythromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Ulcer | 1992 |
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Ranitidine; Recurrence; Risk Factors; Salicylates; Stomach Ulcer; Tetracycline | 1992 |
Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Ranitidine; Salicylates; Single-Blind Method; Tetracycline | 1991 |
Duodenal ulcer relapse after eradication of Helicobacter pylori.
Topics: Amoxicillin; Antacids; Bismuth; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Prospective Studies; Recurrence; Tinidazole | 1991 |
The safety and efficacy of tripotassium dicitrato bismuthate (De-Nol) maintenance therapy in patients with duodenal ulceration.
Topics: Adult; Anti-Ulcer Agents; Bismuth; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds; Recurrence | 1990 |
Medical treatment of antral gastrin cell hyperfunction: role of nonantisecretory therapy.
Topics: Adolescent; Adult; Anti-Ulcer Agents; Bismuth; Cimetidine; Duodenal Ulcer; Enterochromaffin Cells; Female; Gastric Acid; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine | 1990 |
Comparison of qid and bd administration of De-Nol in the short term treatment of duodenal ulcer.
Topics: Adult; Anti-Ulcer Agents; Bismuth; Drug Evaluation; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds | 1989 |
Campylobacter pylori and trials of ulcer recurrence.
Topics: Anti-Ulcer Agents; Bismuth; Campylobacter; Duodenal Ulcer; Humans; Recurrence | 1989 |
Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers.
Topics: Adult; Aged; Antacids; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Female; Gastrins; Humans; Male; Middle Aged; Organometallic Compounds; Patient Compliance; Pepsinogens; Random Allocation; Ranitidine; Recurrence; Smoking; Tablets | 1985 |
Colloidal bismuth subcitrate and two different dosages of cimetidine in the treatment of resistant duodenal ulcer. Preliminary results.
Topics: Adult; Bismuth; Cimetidine; Drug Resistance; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Organometallic Compounds; Random Allocation | 1986 |
Bismuth/ofloxacin combination for duodenal ulcer.
Topics: Anti-Infective Agents; Bismuth; Campylobacter Infections; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Humans; Ofloxacin; Organometallic Compounds; Oxazines; Random Allocation; Salicylates | 1987 |
Campylobacter pylori and ulcer recurrence.
Topics: Bismuth; Campylobacter Infections; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male; Recurrence | 1988 |
[Effect of bismuth subsalicylate versus cimetidine on Campylobacter pylori, ulcer healing and rate of recurrence].
Topics: Adult; Aged; Bismuth; Campylobacter; Campylobacter Infections; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds; Random Allocation; Recurrence; Salicylates; Stomach Ulcer; Wound Healing | 1988 |
Maintenance therapy with colloidal bismuth subcitrate in duodenal ulcer disease.
Topics: Adult; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds; Random Allocation; Time Factors | 1987 |
Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.
Topics: Adult; Aged; Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds; Recurrence | 1986 |
Colloidal bismuth subcitrate in peptic ulcer disease.
Topics: Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Humans; Organometallic Compounds; Peptic Ulcer; Stomach Ulcer | 1986 |
A comparison of colloidal bismuth subcitrate tablets and ranitidine in the treatment of chronic duodenal ulcers.
Topics: Adult; Aged; Anti-Ulcer Agents; Bismuth; Chronic Disease; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds; Random Allocation; Ranitidine | 1986 |
The influence of colloidal bismuth subcitrate on duodenal ulcer relapse.
Topics: Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Humans; Organometallic Compounds; Recurrence | 1986 |
The role of colloidal bismuth subcitrate in the short-term treatment of duodenal ulcer.
Topics: Bismuth; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Humans; Organometallic Compounds; Ranitidine | 1986 |
An international multi-clinic study comparing the therapeutic efficacy of colloidal bismuth subcitrate coated tablets with chewing tablets in the treatment of duodenal ulceration.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Dyspepsia; Female; Humans; Male; Middle Aged; Organometallic Compounds; Random Allocation; Tablets | 1986 |
Colloidal bismuth subcitrate as coated tablets: four times versus twice daily dosage in duodenal ulcer.
Topics: Adult; Bismuth; Clinical Trials as Topic; Drug Administration Schedule; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds; Tablets | 1986 |
[Effect of colloidal bismuth citrate on various components of gastric juice in patients with peptic ulcer].
Topics: Adult; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Female; Gastric Juice; Glycoproteins; Humans; Male; N-Acetylneuraminic Acid; Organometallic Compounds; Sialic Acids | 1986 |
Twice daily tripotassium dicitrato bismuthate in the treatment of duodenal ulceration.
Topics: Adolescent; Adult; Aged; Bismuth; Clinical Trials as Topic; Drug Administration Schedule; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds | 1986 |
A double-blind, endoscopically assessed evaluation of a bismuth subnitrate preparation (Roter) and cimetidine in the treatment of duodenal ulcer.
Topics: Antacids; Bismuth; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged | 1986 |
Use of cytoprotective agents in the treatment of gastric ulcers.
Topics: Aluminum; Bismuth; Carbenoxolone; Clinical Trials as Topic; Duodenal Ulcer; Humans; Organometallic Compounds; Placebos; Prostaglandins; Stomach Ulcer; Sucralfate | 1985 |
Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers.
Topics: Adult; Aged; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds; Solutions; Tablets | 1985 |
[Stimulation of restorative processes in stomach and duodenal ulcers].
Topics: Adolescent; Adult; Anti-Ulcer Agents; Atropine; Bismuth; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Humans; Male; Middle Aged; Nucleic Acids; Stomach Ulcer | 1985 |
Endoscopic controlled trial of four drug regimens in the treatment of chronic duodenal ulceration.
Topics: Adolescent; Adult; Aged; Aluminum Hydroxide; Anti-Ulcer Agents; Bismuth; Chronic Disease; Cimetidine; Clinical Trials as Topic; Drug Combinations; Duodenal Ulcer; Endoscopy; Female; Gefarnate; Glycyrrhiza; Humans; Magnesium Hydroxide; Male; Middle Aged; Plant Extracts; Sodium Bicarbonate | 1985 |
[Comparative evaluation of antacids in duodenal ulcer].
Topics: Aluminum Hydroxide; Antacids; Benzocaine; Bismuth; Calcium Carbonate; Carbonates; Clinical Trials as Topic; Drug Combinations; Duodenal Ulcer; Humans; Magnesium Hydroxide; Sorbitol | 1985 |
[Cimetidine and tripotassium-dicitrato bismuthate (Duosol) in chronic duodenal ulcer].
Topics: Adult; Anti-Ulcer Agents; Bismuth; Cimetidine; Duodenal Ulcer; Duodenoscopy; Female; Humans; Male; Middle Aged; Organometallic Compounds; Smoking | 1985 |
[Controlled study of the action of maintenance therapy between attacks of duodenal ulcer].
Topics: Adult; Aluminum Hydroxide; Bismuth; Duodenal Ulcer; Histidine; Humans; Long-Term Care; Male; Parasympatholytics; Placebos | 1972 |
Caved-S and Ulcedal for peptic ulcer.
Topics: Aluminum Hydroxide; Bismuth; Clinical Trials as Topic; Drug Combinations; Duodenal Ulcer; Glycyrrhiza; Humans; Magnesium Hydroxide; Peptic Ulcer; Plant Extracts; Plants, Medicinal; Sodium Bicarbonate; Stomach Ulcer | 1973 |
[Experiences with Bisuc in stomach diseases].
Topics: Antacids; Anti-Inflammatory Agents; Bicarbonates; Bismuth; Clinical Trials as Topic; Drug Combinations; Duodenal Ulcer; Evaluation Studies as Topic; Foeniculum; Humans; Magnesium; Plants, Medicinal; Plants, Toxic; Rhamnus; Sodium Bicarbonate; Stomach Diseases; Stomach Ulcer | 1973 |
Evaluation of colloidal bismuth (De-Nol) in the treatment of duodenal ulcer employing endoscopic selection and follow up.
Topics: Acid-Base Equilibrium; Adult; Bismuth; Clinical Trials as Topic; Colloids; Duodenal Ulcer; Endoscopy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Placebos | 1974 |
[Treatment of gastroduodenal ulcers through the combination calcium acexamate-light bismuth nitrate].
Topics: Acetates; Adult; Aged; Amines; Bismuth; Calcium; Caproates; Clinical Trials as Topic; Drug Combinations; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Nitrates; Peptic Ulcer; Stomach Ulcer | 1973 |
[Treatment of duodenal ulcer limited to methods of confirmed value].
Topics: Antacids; Ascorbic Acid; Bismuth; Diet Therapy; Duodenal Ulcer; Estrogens; Glycyrrhiza; Histidine; Humans; Methods; Pain; Parasympatholytics; Placebos; Plants, Medicinal; Rest; Smoking | 1973 |
[Clinical studies on peptic ulcer therapy. 2. Ambulatory care of duodental ulcer using bismutum subnitricum].
Topics: Ambulatory Care; Antacids; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Humans | 1968 |
The efficacy of a bismuth-protein-complex compound in the treatment of gastric and duodenal ulcers.
Topics: Adult; Aged; Bismuth; Citrates; Clinical Trials as Topic; Drug Synergism; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Pepsin A; Placebos; Quaternary Ammonium Compounds; Stomach Ulcer | 1971 |
99 other study(ies) available for bismuth and Duodenal Ulcer
| Article | Year |
|---|---|
[Effectiveness of eradication anti-helicobacter therapy in patients with duodenal ulcer in different drug dosage regimens].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Treatment Outcome | 2003 |
[The treatment of duodenal ulcer with bismuth].
Topics: Antacids; Antidiarrheals; Bismuth; Duodenal Ulcer; Humans; Peptic Ulcer | 1954 |
[The parenteral treatment of duodenal ulcer with bismuth].
Topics: Antacids; Antidiarrheals; Bismuth; Duodenal Ulcer; Humans; Peptic Ulcer | 1960 |
[TREATMENT OF PEPTIC ULCER PATIENTS WITH VIKALIN].
Topics: Anions; Antacids; Bicarbonates; Bismuth; Carbonates; Duodenal Ulcer; Humans; Khellin; Magnesium; Peptic Ulcer; Plants, Medicinal; Rutin; Sodium; Stomach Ulcer | 1963 |
[Tripotassium dicitrato bismuthate in the therapy of peptic ulcer: comparison with ranitidine in short-term treatment].
Topics: Adult; Aged; Bismuth; Drug Evaluation; Drug Tolerance; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine; Stomach Ulcer | 1984 |
Relapsing ulcers and mucosal protecting agents.
Topics: Bismuth; Cimetidine; Duodenal Ulcer; Guanidines; Humans; Intestinal Mucosa; Organometallic Compounds | 1981 |
Another look at peptic ulcer.
Topics: Antacids; Bismuth; Chronic Disease; Cimetidine; Colloids; Duodenal Ulcer; Female; Furans; Histamine H2 Antagonists; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine; Stomach Ulcer | 1981 |
Duodenal ulcers that will not heal.
Topics: Anti-Ulcer Agents; Benzimidazoles; Bismuth; Cimetidine; Drug Resistance; Duodenal Ulcer; Humans; Omeprazole; Organometallic Compounds; Ranitidine | 1984 |
[Ulcer therapy without acid inhibition].
Topics: Aluminum; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Humans; Organometallic Compounds; Recurrence; Stomach Ulcer; Sucralfate | 1984 |
[Circadian changes in gastric acidity during drug therapy of duodenal ulcer].
Topics: Adult; Anti-Ulcer Agents; Benzodiazepinones; Bismuth; Butylscopolammonium Bromide; Cimetidine; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acidity Determination; Humans; Male; Pirenzepine | 1983 |
[Comparative evaluation of the efficacy of complex anti-ulcer therapy and monotherapy].
Topics: Adult; Aged; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Humans; Middle Aged; Organometallic Compounds; Stomach Ulcer | 1984 |
Antacids for duodenal ulcer.
Topics: Antacids; Bismuth; Duodenal Ulcer; Humans; Organometallic Compounds | 1981 |
The effect of tri-potassium di-citrato bismuthate on the duodenal mucosa during ulceration. An ultrastructural study.
Topics: Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Duodenum; Humans; Intestinal Mucosa; Organometallic Compounds; Time Factors | 1982 |
Changes in the morphology of villar epithelial cells adjacent to duodenal ulcers during the process of healing.
Topics: Bismuth; Duodenal Ulcer; Duodenum; Epithelium; Humans; Microscopy, Electron; Organometallic Compounds; Time Factors; Wound Healing | 1982 |
The medical treatment of chronic gastric and duodenal ulceration.
Topics: Antacids; Bismuth; Cimetidine; Colloids; Duodenal Ulcer; Humans; Peptic Ulcer; Stomach Ulcer | 1981 |
The modern treatment of peptic ulceration.
Topics: Antacids; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Guanidines; Humans; Peptic Ulcer; Recurrence; Stomach Ulcer | 1981 |
[Is measurement of basal levels of serum pepsinogen II useful in proving the eradication of Helicobacter pylori by treatment?].
Topics: Adult; Aged; Antacids; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pepsinogens; Prospective Studies; Radioimmunoassay; ROC Curve; Sensitivity and Specificity; Stomach; Tetracycline; Time Factors | 1995 |
[The importance of obtaining biopsies of the gastric body in the follow-up after eradicating treatment of Helicobacter pylori].
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Biopsy; Bismuth; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Penicillins; Prospective Studies; Pyloric Antrum; Stomach; Tetracycline; Time Factors | 1995 |
Helicobacter pylori and upper gastrointestinal disease: a survey of gastroenterologists in the United Kingdom.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Chronic Disease; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Gastroenterology; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medical Staff, Hospital; Microbial Sensitivity Tests; Middle Aged; Patient Selection; Practice Patterns, Physicians'; Recurrence; Stomach Ulcer; United Kingdom | 1995 |
[Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Duodenitis; Evaluation Studies as Topic; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer; Stomach Ulcer; Time Factors | 1995 |
Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy.
Topics: Abdominal Pain; Adolescent; Amoxicillin; Antibodies, Bacterial; Bismuth; Child; Child, Preschool; Duodenal Ulcer; Endoscopy, Gastrointestinal; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Metronidazole; Organometallic Compounds; Polymerase Chain Reaction; Recurrence; Salicylates; Stomach Ulcer | 1995 |
"Cure" of Helicobacter pylori and "cure" of peptic ulcer: do they mean the same thing?
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Recurrence; Tetracycline; Time Factors | 1995 |
Duodenal ulcer healing drugs.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Gastric Acid; Gastrin-Releasing Peptide; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptides | 1994 |
Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation.
Topics: Adult; Aged; Bismuth; Cell Division; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Longitudinal Studies; Male; Metaplasia; Metronidazole; Middle Aged; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Pyloric Antrum; Tetracycline | 1994 |
Phospholipase A2 activity in gastric juice from patients with active and H. pylori-eradicated healed duodenal ulcer.
Topics: Adult; Aged; Bile Acids and Salts; Bismuth; Choline; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged; Oxytetracycline; Phospholipases A; Phospholipases A2; Phospholipids | 1994 |
Effect of eradication of Helicobacter pylori on serum pepsinogen I, gastrin, and insulin in duodenal ulcer patients: a 12-month follow-up study.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Insulin; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pepsinogens; Time Factors | 1994 |
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Recurrence; Salicylates; Stomach Ulcer | 1994 |
Omeprazole/amoxicillin versus ranitidine/triple therapy for duodenal ulcer: when is the "same" the same?
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Ranitidine; Salicylates; Tetracycline | 1994 |
[A trial of modified triple therapy for the eradication of H. pylori in recurrent duodenal ulcer].
Topics: Adult; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Ornidazole; Penicillin G Benzathine; Prospective Studies; Recurrence | 1993 |
Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Biochemical and biophysical studies.
Topics: Anti-Bacterial Agents; Bismuth; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Organometallic Compounds; Phospholipases A; Phospholipases A1; Phospholipases A2; Stomach Ulcer; Type C Phospholipases | 1993 |
Treatment and long-term follow-up of Helicobacter pylori-associated duodenal ulcer disease in children.
Topics: Adolescent; Amoxicillin; Biopsy; Bismuth; Child; Child, Preschool; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Organometallic Compounds; Pyloric Antrum; Recurrence; Salicylates; Time Factors; Treatment Outcome | 1993 |
[Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease].
Topics: Administration, Oral; Adult; Aged; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Ranitidine; Salicylates; Tetracycline | 1993 |
Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori.
Topics: Acute Disease; Adult; Aged; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Gastric Acid; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Parietal Cells, Gastric; Tetracycline | 1993 |
The role of Helicobacter pylori in peptic ulcer disease.
Topics: Amoxicillin; Antacids; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Metronidazole; Neutrophils; Prospective Studies; Recurrence; Stomach Ulcer | 1993 |
[The effect of colloidal bismuth and its combination with amoxicillin on the elimination of Helicobacter pylori in patients with a duodenal ulcer and chronic antral gastritis].
Topics: Adult; Aged; Amoxicillin; Bismuth; Chronic Disease; Colloids; Drug Evaluation; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pyloric Antrum | 1993 |
Eradication of Helicobacter pylori normalizes serum gastrin concentration and antral gastrin cell number in a patient with primary gastrin cell hyperplasia.
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Enterochromaffin Cells; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Male; Metronidazole; Middle Aged; Pyloric Antrum; Tetracycline | 1993 |
Local cellular and immune response by antral mucosa in patients undergoing treatment for eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulins; Male; Metronidazole; Middle Aged; Omeprazole; Pyloric Antrum; T-Lymphocytes; Tetracycline | 1993 |
[Eradication of Helicobacter pylori and hemorrhagic recurrence of duodenal ulcer].
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer Hemorrhage; Tetracycline; Time Factors | 1995 |
Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Omeprazole; Patient Compliance; Penicillins; Recurrence; Tetracycline; Time Factors | 1996 |
[What factors influence healing of duodenal ulcer when Helicobacter pylori eradication treatment is used?].
Topics: Adult; Age Factors; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Evaluation Studies as Topic; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Multivariate Analysis; Omeprazole; Penicillins; Sex Factors; Smoking; Tetracycline; Time Factors; Wound Healing | 1996 |
Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Ranitidine; Recurrence; Time Factors | 1996 |
Helicobacter pylori reinfection after apparent eradication--the Ipswich experience.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Case-Control Studies; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; England; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Recurrence; Stomach Ulcer; Time Factors; Urea | 1996 |
[Which factors influence the success of the classical triple therapy in the eradication of Helicobacter pylori?].
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Pyloric Antrum; Stomach; Tetracycline | 1996 |
Bismuth concentration in blood and urine of children treated with ventrisol (polfa) preliminary study.
Topics: Adolescent; Bismuth; Child; Duodenal Ulcer; Gastritis; Humans; Organometallic Compounds; Pilot Projects | 1995 |
Ranitidine bismuth citrate therapy.
Topics: Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine | 1996 |
Helicobacter pylori reinfection is rare in peptic ulcer patients cured by antimicrobial therapy.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Recurrence; Salicylates; Stomach Ulcer; Time Factors; Tinidazole | 1996 |
Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Recurrence; Risk Factors; Smoking; Stomach Ulcer; Sucralfate; Wound Healing | 1997 |
Triple-drug therapy of Helicobacter pylori infection in duodenal ulcer disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Recurrence; Tetracycline; Time Factors | 1997 |
Cure of Helicobacter pylori: a hidden curse?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Esophagitis, Peptic; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Risk Factors; Salicylates; Sex Factors; Weight Gain | 1997 |
[Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Combinations; Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Helicobacter pylori; Histamine H2 Antagonists; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors; Ranitidine; Receptors, Histamine H2; Stomach Ulcer | 1998 |
Peptic ulcer treatment today--is there a role for maintenance therapy?
Topics: Antacids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Chronic Disease; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer; Peptic Ulcer Hemorrhage; Recurrence | 1997 |
[Evaluation of results of surgical treatment of peptic ulcer associated with Helicobacter pylori].
Topics: Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Evaluation Studies as Topic; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Stomach Ulcer | 1998 |
Long-term follow-up of duodenal ulcer in children before and after eradication of Helicobacter pylori.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Bismuth; Child; Disease Progression; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole | 1999 |
Optimal treatment for duodenal ulcer disease: a cost-decision analysis in Malaysian patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Decision Support Techniques; Drug Therapy, Combination; Duodenal Ulcer; Humans; Malaysia; Metronidazole; Models, Economic; Omeprazole; Tetracycline | 1999 |
Duodenal ulcer disease: to treat H. pylori infection or not?
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Ranitidine; Tetracycline; United States | 1992 |
Treatment of Helicobacter pylori: where are we now? What are the key questions?
Topics: Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Treatment Outcome; United Kingdom | 1999 |
In search of the Holy Grail of Heliocobacter pylori remedies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Helicobacter Infections; Humans; Metronidazole; Pilot Projects; Ranitidine; Spain | 2001 |
Diagnostic methods for detecting forms and strains of Helicobacter pylori and evaluation of its eradication.
Topics: Adolescent; Adult; Aged; Antibodies, Bacterial; Bismuth; DNA Fingerprinting; Duodenal Ulcer; Female; Flagellin; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Ranitidine; Recurrence; Restriction Mapping; Species Specificity; Time Factors; Urease | 2001 |
Does the duodenal cell ever return to normal? A comparison between treatment with cimetidine and denol.
Topics: Anti-Ulcer Agents; Bismuth; Cimetidine; Duodenal Ulcer; Duodenum; Guanidines; Humans; Microvilli; Organometallic Compounds; Time Factors | 1979 |
Histamine H2 antagonists.
Topics: Animals; Bismuth; Carbenoxolone; Chemical Phenomena; Chemistry; Cimetidine; Duodenal Ulcer; Gastric Juice; Gastroesophageal Reflux; Guanidines; Humans; Stomach Ulcer | 1979 |
Drugs for peptic ulcer.
Topics: Antacids; Bismuth; Carbenoxolone; Chelating Agents; Cimetidine; Duodenal Neoplasms; Duodenal Ulcer; Humans; Peptic Ulcer; Peptic Ulcer Hemorrhage; Stomach Neoplasms; Stomach Ulcer | 1979 |
Tri-potassium di-citrato bismuthate: a report of its pharmacological properties and therapeutic efficacy in peptic ulcer.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Dogs; Dose-Response Relationship, Drug; Drug Evaluation; Drug Evaluation, Preclinical; Duodenal Ulcer; Female; Humans; Male; Peptic Ulcer; Rats; Stomach Ulcer | 1976 |
[A case of strongyloidiasis accompanied by duodenal ulcer].
Topics: Albendazole; Animals; Bismuth; Duodenal Ulcer; Humans; Male; Middle Aged; Strongyloides stercoralis; Strongyloidiasis | 1992 |
[Treatment of stomach ulcer with bismuth subnitrate, oxytetracycline and metronidazole].
Topics: Adult; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Oxytetracycline; Recurrence; Stomach Ulcer | 1992 |
[Duodenal ulcers that do not heal for a long time].
Topics: Adult; Aluminum Hydroxide; Antacids; Anti-Ulcer Agents; Benzocaine; Bismuth; Cimetidine; Drug Combinations; Duodenal Ulcer; Humans; Magnesium Hydroxide; Sucralfate; Time Factors; Wound Healing | 1992 |
Eicosanoid synthesis in duodenal ulcer disease: decrease in leukotriene C4 by colloidal bismuth subcitrate.
Topics: Adult; Aged; Bismuth; Calcimycin; Dinoprostone; Duodenal Ulcer; Duodenum; Eicosanoids; Female; Humans; Intestinal Mucosa; Male; Middle Aged; Organometallic Compounds; SRS-A | 1992 |
Short report: short-term triple therapy for H. pylori-associated duodenal ulcer disease.
Topics: Adult; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Tetracycline | 1992 |
[Helicobacter pylori: from harmless commensal to clinically significant disease factor].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Recurrence; Stomach Ulcer; Tetracycline | 1992 |
Factors influencing the eradication of Helicobacter pylori with triple therapy.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Patient Compliance; Regression Analysis; Salicylates; Stomach Ulcer; Tetracycline | 1992 |
Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Circadian Rhythm; Duodenal Ulcer; Female; Gastric Acid; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged; Organometallic Compounds; Stomach; Time Factors | 1991 |
Spiral shaped microorganisms in the human duodenal mucosa.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Duodenum; Gram-Negative Bacteria; Humans; Intestinal Mucosa; Male; Metronidazole; Organometallic Compounds | 1991 |
[Current insights in the pathogenesis and treatment of duodenal ulcer].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Humans; Organometallic Compounds | 1991 |
Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Campylobacter Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Humans; Metronidazole; Organometallic Compounds | 1990 |
Systemic chemotherapy for Helicobacter pylori eradication?
Topics: Administration, Oral; Bismuth; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Salicylates | 1990 |
Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection.
Topics: Bismuth; Campylobacter Infections; Drug Therapy, Combination; Duodenal Ulcer; Female; Food; Gastrins; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Tetracycline | 1990 |
[Helicobacter pylori-induced cost-benefit risk considerations].
Topics: Bismuth; Campylobacter Infections; Cost-Benefit Analysis; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Histamine H2 Antagonists; Humans; Male; Risk Factors; Stomach Ulcer | 1989 |
[Prevention of recurrence with bismuth subsalicylate in a patient with recurrent and H2 receptor antagonist refractory duodenal ulcer].
Topics: Anti-Ulcer Agents; Bismuth; Cimetidine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine; Recurrence; Salicylates | 1989 |
Effect of Nilacid treatment in ulcer.
Topics: Adult; Antacids; Bismuth; Drug Combinations; Duodenal Ulcer; Female; Humans; Magnesium; Magnesium Hydroxide; Male; Middle Aged; Phosphates; Silicic Acid; Silicon Dioxide; Stomach Ulcer | 1986 |
Peptic ulcer disease: physiology and pathophysiology.
Topics: Antacids; Aspirin; Bismuth; Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Parasympatholytics; Parietal Cells, Gastric; Pepsinogens; Peptic Ulcer; Prostaglandins; Smoking; Stomach; Stomach Ulcer | 1985 |
The drug treatment of duodenal ulcer: physiological considerations in the choice of therapy.
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Carbenoxolone; Dinoprostone; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Intestinal Mucosa; Omeprazole; Organometallic Compounds; Parasympatholytics; Prostaglandins E; Sucralfate; Trimipramine | 1986 |
Relapse of duodenal ulcer.
Topics: Bismuth; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Organometallic Compounds; Recurrence | 1986 |
Sensitivity of Campylobacter pylori to colloidal bismuth subcitrate.
Topics: Bismuth; Campylobacter; Duodenal Ulcer; Humans; Organometallic Compounds | 1989 |
[Combined drug therapy against Campylobacter in duodenal ulcer and non-ulcerous dyspepsia].
Topics: Anti-Bacterial Agents; Bismuth; Campylobacter Infections; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Humans | 1989 |
Acid, pepsin, and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol).
Topics: Adult; Aged; Bismuth; Duodenal Ulcer; Female; Gastric Acid; Gastric Mucosa; Humans; Male; Middle Aged; Mucus; Organometallic Compounds; Pepsin A; Stomach Ulcer | 1986 |
Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?
Topics: Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Humans; Organometallic Compounds; Recurrence | 1986 |
Monotherapy or polychemotherapy in the treatment of Campylobacter pylori-related gastroduodenal disease.
Topics: Adult; Biopsy; Bismuth; Campylobacter Infections; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Humans; Male; Middle Aged; Nitrofurantoin; Organometallic Compounds; Pilot Projects; Pyloric Antrum; Salicylates; Stomach Ulcer; Urease | 1988 |
Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin.
Topics: Adolescent; Ampicillin; Bismuth; Campylobacter; Campylobacter Infections; Child; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Humans; Organometallic Compounds; Pyloric Antrum; Salicylates | 1988 |
Neuropsychiatric symptoms following bismuth intoxication.
Topics: Adult; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Humans; Male; Organometallic Compounds; Substance-Related Disorders | 1988 |
Campylobacter pyloridis and gastritis.
Topics: Achlorhydria; Biopsy; Bismuth; Campylobacter; Campylobacter Infections; Cimetidine; Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Gastritis; History, 20th Century; Humans; Stomach Ulcer; Urease | 1986 |
[Therapy of peptic ulcer and chronic gastritis with bismuth salts].
Topics: Anti-Ulcer Agents; Bismuth; Campylobacter Infections; Chronic Disease; Duodenal Ulcer; Gastritis; Humans; Organometallic Compounds; Peptic Ulcer; Salicylates; Stomach Ulcer | 1987 |
Cytoprotective agents and ulcer relapse.
Topics: Aluminum; Antacids; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Humans; Organometallic Compounds; Peptic Ulcer; Recurrence; Stomach Ulcer; Sucralfate | 1985 |
Factors relevant to the prognosis of chronic duodenal ulcer.
Topics: Age Factors; Alcohol Drinking; Analgesics; Bismuth; Carbenoxolone; Chronic Disease; Cimetidine; Drug Therapy, Combination; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Prognosis; Risk; Sex Factors; Smoking; Wound Healing | 1985 |
Appropriate statistical test in comparative ulcer healing studies.
Topics: Bismuth; Cimetidine; Duodenal Ulcer; Humans; Organometallic Compounds; Statistics as Topic | 1985 |
[Ulcer therapy without acid inhibition].
Topics: Bismuth; Duodenal Ulcer; Humans; Mouth Mucosa; Organometallic Compounds | 1985 |
De-Nol for gastric and duodenal ulcers.
Topics: Bismuth; Citrates; Duodenal Ulcer; Gastric Mucosa; Humans; Organometallic Compounds; Stomach Ulcer | 1972 |
[Experimental clinical study with agel-bismuth in the treatment of gastroduodenal lesions].
Topics: Adolescent; Adult; Bismuth; Capsules; Duodenal Ulcer; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Stomach Ulcer | 1973 |
A multi-centre pilot study of tri-potassium di-citrato bismuthate ('De-Nol') in general practice.
Topics: Administration, Oral; Adolescent; Adult; Aged; Bismuth; Citrates; Duodenal Ulcer; Family Practice; Female; Gastrointestinal Agents; Humans; Male; Middle Aged; Pain; Peptic Ulcer; Pilot Projects; Radiography; Stomach Ulcer; Vomiting | 1973 |
[Comparative evaluation of the efficacy of treatment of peptic ulcer with atropine, metacin and vikalin].
Topics: Adult; Atropine; Bismuth; Carbonates; Duodenal Ulcer; Humans; Magnesium; Male; Middle Aged; Parasympatholytics; Stomach Ulcer | 1972 |
[Observations on the therapeutic modification of various gastric disorders with a new combined action agent "Antul"].
Topics: Aluminum; Antacids; Anti-Infective Agents; Bismuth; Duodenal Ulcer; Gastritis; Humans; Magnesium; Stomach Diseases; Stomach Neoplasms; Stomach Ulcer | 1966 |